Pharmaceutical Industry Information Portal

HomeManufacturers News

Manufacturers News

ChemRar Group announces the Russian Avifavir® drug is effective against variants of COVID-19, including Delta and Omicron

ChemRar Group announces the Russian Avifavir® (INN: favipiravir) drug is effective against various variants of SARS-CoV-2 (coronavirus), including Delta and Omicron, as it affects...

Russian Ministry of Health registered Mir-19 anti-coronavirus drug

The Russian Ministry of Health registered the Mir-19 coronavirus pharmaceuticals developed by the Russian Federal Medical-Biological Agency (FMBA), the agency’s press service said. The press...

Pfizer Receives U.S. FDA Emergency Use Authorization for Novel COVID-19 Oral Antiviral Treatment

Pfizer Inc. announced that the U.S. Food and Drug Administration (FDA) has authorized the emergency use of PAXLOVID™ (nirmatrelvir tablets and ritonavir tablets)...

NANOLEK began industrial production of the CoviVac vaccine

NANOLEK announced the launch of industrial production of CoviVac. Investments in this project amounted to 40 million rubles, the company said. The manufacturer plans...

Pharmasyntez-Nord JSC starts manufacturing the Sputnik Light vaccine developed by Gamaleya Research Center

Investments in the vaccine production are over 2 billion rubles. The production capacity is about 4 million vaccine doses per month. When the domestic market is...

Phase 3 clinical trial results of Coronavir (favipiravir) published in US Journal

The American Journal of Translational Research has published successful results of the Phase 3 clinical trial of Coronavir (INN: favipiravir). This study aimed to evaluate the efficacy and safety of favipiravir for treatment of mild...
spot_img

Expert Articles

spot_img